Leukocyte antibacterial functions are not impaired by perfluorocarbon exposure in vitro

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 295, Issue 1, 2008, Pages

  Haufe, Dirk ^a   Koenigshausen, Eva ^a   Knels, Lilla ^a,b   Wendel, Martina ^a   Stehr, Sebastian N ^a   Koch, Thea ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Anti inflammatory; Burst; Immune; Perfluorohexane; Phagocytosis

Indexed keywords

FLUOROCARBON; ANTIINFLAMMATORY AGENT;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIUM ADHERENCE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE FUNCTION; MONOCYTE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ADULT RESPIRATORY DISTRESS SYNDROME; BIOLOGICAL MODEL; DRUG EFFECT; ESCHERICHIA COLI K 12; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; RESPIRATORY BURST; ULTRASTRUCTURE;

ANTI-INFLAMMATORY AGENTS; ESCHERICHIA COLI K12; FLUOROCARBONS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MODELS, BIOLOGICAL; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; RESPIRATORY BURST; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 49049101957     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00338.2007     Document Type: Article

References (52)

1. Baba A, Kim YK, Zhang H, Liu M, Slutsky AS. Perfluorocarbon blocks tumor necrosis factor-alpha-induced interleukin-8 release from alveolar epithelial cells in vitro. Crit Care Med 28: 1113-1118, 2000.
2. Babcock HM, Zack JE, Garrison T, Trovillion E, Kollef MH, Fraser VJ. Ventilator-associated pneumonia in a multi-hospital system: differences in microbiology by location. Infect Control Hosp Epidemiol 24: 853-858, 2003.
3. Bleyl JU, Ragaller M, Tscho U, Regner M, Kanzow M, Hubler M, Rasche S, Albrecht M. Vaporized perfluorocarbon improves oxygenation and pulmonary function in an ovine model of acute respiratory distress syndrome. Anesthesiology 91: 461-469, 1999.
4. Brain JD, Molina RM, DeCamp MM, Warner AE. Effects of a perfluorochemical emulsion on the fate of circulating Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 276: L1037-L1045, 1999.
5. Chang H, Kuo FC, Lai YS, Chou TC. Inhibition of inflammatory responses by FC-77, a perfluorochemical, in lipopolysaccharide-treated RAW 264.7 macrophages. Intensive Care Med 31: 977-984, 2005.
6. Coldren CD, Nick JA, Poch KR, Woolum MD, Fouty BW, O'Brien JM, Gruber MP, Zamora MR, Svetkauskaite D, Richter DA, He Q, Park JS, Overdier KH, Abraham E, Geraci MW. Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am J Physiol Lung Cell Mol Physiol 291: L1267-L1276, 2006.
7. Croce MA, Fabian TC, Patton JH Jr, Melton SM, Moore M, Trenthem LL. Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. J Trauma 45: 273-280, 1998.
8. De Abreu MG, Quelhas AD, Spieth P, Brauer G, Knels L, Kasper M, Pino AV, Bleyl JU, Hubler M, Bozza F, Salluh J, Kuhlisch E, Giannella-Neto A, Koch T. Comparative effects of vaporized perfluorohexane and partial liquid ventilation in oleic acid-induced lung injury. Anesthesiology 104: 278-289, 2006.
9. Dickson EW, Heard SO, Chu B, Fraire A, Brueggemann AB, Doern GV. Partial liquid ventilation with perfluorocarbon in the treatment of rats with lethal pneumococcal pneumonia. Anesthesiology 88: 218-223, 1998.
10. Dickson EW, Heard SO, Tarara TE, Weers JG, Brueggemann AB, Doern GV. Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumonia. Crit Care Med 30: 393-395, 2002.
11. Fagon JY, Chastre J. Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients. Eur Respir J Suppl 42: 77s-83s, 2003.
12. Fernandez R, Sarma V, Younkin E, Hirschl RB, Ward PA, Younger JG. Exposure to perflubron is associated with decreased Syk phosphorylation in human neutrophils. J Appl Physiol 91: 1941-1947, 2001.
13. Gama de AM, Wilmink B, Hubler M, Koch T. Vaporized perfluorohexane attenuates ventilator-induced lung injury in isolated, perfused rabbit lungs. Anesthesiology 102: 597-605, 2005.
14. Ginis I, Tauber AI. Activation mechanisms of adherent human neutrophils. Blood 76: 1233-1239, 1990.
15. Haufe D, Luther T, Kotzsch M, Knels L, Koch T. Perfluorocarbon attenuates response of concanavalin A-stimulated mononuclear blood cells without altering ligand-receptor interaction. Am J Physiol Lung Cell Mol Physiol 287: L210-L216, 2004.
16. Heller AR, Heller SC, Borkenstein A, Stehr SN, Koch T. Modulation of host defense by hydrocortisone in stress doses during endotoxemia. Intensive Care Med 29: 1456-1463, 2003.
17. Hirschl RB, Croce M, Gore D, Wiedemann H, Davis K, Zwischenberger J, Bartlett RH. Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med 165: 781-787, 2002.
18. Hirschl RB, Pranikoff T, Wise C, Overbeck MC, Gauger P, Schreiner RJ, Dechert R, Bartlett RH. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA 275: 383-389, 1996.
19. Hirschl RB, Tooley R, Parent A, Johnson K, Bartlett RH. Evaluation of gas exchange, pulmonary compliance, and lung injury during total and partial liquid ventilation in the acute respiratory distress syndrome. Crit Care Med 24: 1001-1008, 1996.
20. Jeng MJ, Soong WJ, Lee YS, Chang HL, Shen CM, Wang CH, Yang SS, Hwang B. Effects of therapeutic bronchoalveolar lavage and partial liquid ventilation on meconium-aspirated newborn piglets. Crit Care Med 34: 1099-1105, 2006.
21. Jiang L, Wang Q, Liu Y, Du M, Shen X, Xie N, Wu S. Effect of different ventilation modes with FC-77 on pulmonary inflammatory reaction in piglets after cardiopulmonary bypass. Pediatr Pulmonol 42: 150-158, 2007.
22. Jones HA, Schofield JB, Krausz T, Boobis AR, Haslett C. Pulmonary fibrosis correlates with duration of tissue neutrophil activation. Am J Respir Crit Care Med 158: 620-628, 1998.
23. Jung R, Pendland SL, Martin SJ. Effect of perfluorooctyl bromide on bacterial growth. Chemotherapy 49: 1-7, 2003.
24. Kacmarek RM, Wiedemann HP, Lavin PT, Wedel MK, Tutuncu AS, Slutsky AS. Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 173: 882-889, 2006.
25. Koch T, Ragaller M, Haufe D, Hofer A, Grosser M, Albrecht DM, Kotzsch M, Luther T. Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages. Anesthesiology 94: 101-109, 2001.
26. Lane TA, Lamkin GE. Paralysis of phagocyte migration due to an artificial blood substitute. Blood 64: 400-405, 1984.
27. Leach CL, Greenspan JS, Rubenstein SD, Shaffer TH, Wolfson MR, Jackson JC, DeLemos R, Fuhrman BP. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The LiquiVent Study Group. N Engl J Med 335: 761-767, 1996.
28. Li Y, Karlin A, Loike JD, Silverstein SC. A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc Natl Acad Sci USA 99: 8289-8294, 2002.
29. Moreira CA Jr, Bryk A Jr, Komatsu MC, Vanzo LC. Bacterial growth in perfluorocarbon liquids: an in vitro study. Retina 21: 533-535, 2001.
30. Nakstad B, Wolfson MR, Shaffer TH, Kahler H, Lindemann R, Fugelseth D, Lyberg T. Perfluorochemical liquids modulate cell-mediated inflammatory responses. Crit Care Med 29: 1731-1737, 2001.
31. Obraztsov VV, Neslund GG, Kornbrust ES, Flaim SF, Woods CM. In vitro cellular effects of perfluorochemicals correlate with their lipid solubility. Am J Physiol Lung Cell Mol Physiol 278: L1018-L1024, 2000.
32. Pakulla MA, Seidel D, Obal D, Loer SA. Hydrochloric acid-induced lung injury: effects of early partial liquid ventilation on survival rate, gas exchange, and pulmonary neutrophil accumulation. Intensive Care Med 30: 2110-2119, 2004.
33. Park DR. The microbiology of ventilator-associated pneumonia. Respir Care 50: 742-763, 2005.
34. Rada BK, Geiszt M, Kaldi K, Timar C, Ligeti E. Dual role of phagocytic NADPH oxidase in bacterial killing. Blood 104: 2947-2953, 2004.
35. Rezaiguia-Delclaux S, Yang K, Stephan F, Lemaire F, Meignan M, Harf A, Duvaldestin P, Delclaux C. Effect of partial liquid ventilation on bacterial clearance during Pseudomonas aeruginosa-induced lung injury in rats. Intensive Care Med 29: 1151-1156, 2003.
36. Ricard JD, Iserin F, Dreyfuss D, Saumon G. Perflubron dosing affects ventilator-induced lung injury in rats with previous lung injury. Crit Care Med 35: 561-567, 2007.
37. Rossman JE, Caty MG, Rich GA, Karamanoukian HL, Azizkhan RG. Neutrophil activation and chemotaxis after in vitro treatment with perfluorocarbon. J Pediatr Surg 31: 1147-1150, 1996.
38. Rotta AT, Gunnarsson B, Fuhrman BP, Wiryawan B, Hernan LJ, Steinhorn DM. Perfluorooctyl bromide (perflubron) attenuates oxidative injury to biological and nonbiological systems. Pediatr Crit Care Med 4: 233-238, 2003.
39. Rotta AT, Steinhorn DM. Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoxemia and acute lung injury. Crit Care Med 26: 1707-1715, 1998.
40. Rudiger M, Kopke U, Prosch S, Rauprich P, Wauer RR, Herting E. Effects of perfluorocarbons and perfluorocarbons/surfactant emulsions on growth and viability of group B streptococci and Escherichia coli. Crit Care Med 29: 1786-1791, 2001.
41. Sajan I, Scannapieco FA, Fuhrman BP, Steinhorn DM. The risk of nosocomial pneumonia is not increased during partial liquid ventilation. Crit Care Med 27: 2741-2747, 1999.
42. Schoof E, von der Hardt K, Kandler MA, Abendroth F, Papadopoulos T, Rascher W, Dotsch J. Aerosolized perfluorocarbon reduces adhesion molecule gene expression and neutrophil sequestration in acute respiratory distress. Eur J Pharmacol 457: 195-200, 2002.
43. Smith DJ, Kornbrust ES, Lane TA. Phagocytosis of a fluorescently labeled perflubron emulsion by a human monocyte cell line. Artif Cells Blood Substit Immobil Biotechnol 22: 1215-1221, 1994.
44. Smith TM, Steinhorn DM, Thusu K, Fuhrman BP, Dandona P. A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med 23: 1533-1539, 1995.
45. Spieth PM, Knels L, Kasper M, Domingues QA, Wiedemann B, Lupp A, Hubler M, Gianella NA, Koch T, Gama de AM. Effects of vaporized perfluorohexane and partial liquid ventilation on regional distribution of alveolar damage in experimental lung injury. Intensive Care Med.: 2006.
46. Thomassen MJ, Buhrow LT, Wiedemann HP. Perflubron decreases inflammatory cytokine production by human alveolar macrophages. Crit Care Med 25: 2045-2047, 1997.
47. Varani J, Hirschl RB, Dame M, Johnson K. Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Shock 6: 339-344, 1996.
48. Virmani R, Warren D, Rees R, Fink LM, English D. Effects of perfluorochemical on phagocytic function of leukocytes. Transfusion 23: 512-515, 1983.
49. Von der Hardt K, Kandler MA, Fink L, Schoof E, Dotsch J, Bohle RM, Rascher W. Laser-assisted microdissection and real-time PCR detect anti-inflammatory effect of perfluorocarbon. Am J Physiol Lung Cell Mol Physiol 285: L55-L62, 2003.
50. Von der Hardt K, Schoof E, Kandler MA, Dotsch J, Rascher W. Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr Res 51: 177-182, 2002.
51. Wissel H, Burkhardt W, Rupp J, Wauer RR, Rudiger M. Perfluorocarbons decrease Chlamydophila pneumoniae-mediated inflammatory responses of rat type II pneumocytes in vitro. Pediatr Res 60: 264-269, 2006.
52. Woods CM, Neslund G, Kornbrust E, Flaim SF. Perflubron attenuates neutrophil adhesion to activated endothelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 278: L1008-L1017, 2000.